CAR-T(CAR-T)细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CAR-T(CAR-T)细胞在血液系统恶性肿瘤中的应用推动了这种免疫治疗形式的显著进展。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Single-cell multiomics reveals regulatory mechanisms of CAR T-cell persistence and dysfunction in multiple myeloma.
Single-cell multiomics reveals regulatory mechanisms of CAR T-cell persistence and dysfunction in multiple myeloma.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
理解驱动多发性骨髓瘤(MM)中嵌合抗原受体(CAR)T细胞功能和持续存在的机制,仍是改善治疗结局的关键挑战。在本研究中,我们应用单细胞多组学和基因调控网络分析,对MM患者纵向采集的骨髓(BM)和外周血(PB)样本中靶向B细胞成熟抗原的CAR-T 细胞的转录动态和克隆演化进行了表征。
我们的结果揭示,浸润BM的CAR-T 细胞比其PB对应细胞表现出更活化和耗竭的表型,关键转录调控因子驱动了这些变化。效应向记忆转换的失调导致终末分化CAR-T 细胞增多,与持续存在不良相关。
此外,我们在一名部分缓解患者BM中鉴定出一个高度扩增的CAR-T 细胞克隆,其特征为白细胞介素-10(IL-10)表达升高。功能分析表明,刺激内源性T细胞受体(TCR)增强了IL-10产生,可能促成了CAR-T 细胞增殖和持续存在受损。这些发现揭示了影响CAR-T 细胞动态的调控机制,为改善MM中CAR-T 细胞持续存在和治疗疗效提供了新见解,并突出了优化MM患者CAR-T 细胞治疗的潜在分子靶点。
Understanding the mechanisms that drive chimeric antigen receptor (CAR) T-cell function and persistence in multiple myeloma (MM) remains a critical challenge for improving therapeutic outcomes. In this study, we applied single-cell multiomics and gene regulatory network analysis to characterize the transcriptional dynamics and clonal evolution of B-cell maturation antigen-targeted CAR T-cells in longitudinally collected bone marrow (BM) and peripheral blood (PB) samples from patients with MM.
Our results revealed that CAR T cells infiltrating BM exhibited a more activated and exhausted phenotype than their PB counterparts, with key transcriptional regulators driving these changes. Dysregulation in the effector-to-memory transition led to increased presence of terminally differentiated CAR T-cells, correlating with poor persistence.
Additionally, we identified a hyperexpanded CAR T-cell clone in the BM of a patient in partial response, marked by elevated interleukin-10 (IL-10) expression. Functional analyses demonstrated that stimulation of endogenous T-cell receptor (TCR) enhanced IL-10 production, potentially contributing to impaired CAR T-cell proliferation and persistence.
These findings uncover regulatory mechanisms influencing CAR T-cell dynamics, offering new insights into improving CAR T-cell persistence and therapeutic efficacy in MM, and highlight potential molecular targets for optimizing CAR T-cell therapy in patients with MM.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。